Name | Symbol | Markt | Aktientyp |
---|---|---|---|
ProQR Therapeutics NV | PRQR | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
1,99 | 1,97 | 2,05 | 2,01 | 1,99 |
Aktuelle News
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
15.2.2024 | 13:46 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
14.2.2024 | 12:08 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
09.2.2024 | 12:37 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
19.1.2024 | 13:08 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
05.1.2024 | 13:08 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
07.11.2023 | 16:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
27.9.2023 | 13:06 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
14.9.2023 | 23:20 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
03.8.2023 | 13:15 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
01.8.2023 | 13:15 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |